NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 270 filers reported holding NOVOCURE LTD in Q1 2020. The put-call ratio across all filers is 1.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,854,068 | -68.0% | 362,481 | -17.7% | 0.00% | -75.0% |
| Q2 2023 | $18,279,175 | -31.9% | 440,462 | -1.3% | 0.00% | -33.3% |
| Q1 2023 | $26,839,941 | -19.6% | 446,291 | -1.9% | 0.01% | -25.0% |
| Q4 2022 | $33,367,840 | -6.5% | 454,913 | -3.2% | 0.01% | -11.1% |
| Q3 2022 | $35,690,000 | +31.1% | 469,746 | +19.9% | 0.01% | +50.0% |
| Q2 2022 | $27,233,000 | +0.1% | 391,847 | +19.4% | 0.01% | +20.0% |
| Q1 2022 | $27,195,000 | +9.1% | 328,244 | -1.2% | 0.01% | +25.0% |
| Q4 2021 | $24,935,000 | -34.4% | 332,104 | +1.4% | 0.00% | -42.9% |
| Q3 2021 | $38,030,000 | -47.8% | 327,363 | -0.3% | 0.01% | -50.0% |
| Q2 2021 | $72,797,000 | +52.0% | 328,185 | -9.4% | 0.01% | +40.0% |
| Q1 2021 | $47,883,000 | -30.2% | 362,253 | -8.7% | 0.01% | -33.3% |
| Q4 2020 | $68,624,000 | +85.3% | 396,579 | +19.2% | 0.02% | +66.7% |
| Q3 2020 | $37,040,000 | +109.7% | 332,768 | +11.7% | 0.01% | +80.0% |
| Q2 2020 | $17,665,000 | -23.0% | 297,893 | -12.5% | 0.01% | -37.5% |
| Q1 2020 | $22,936,000 | -23.4% | 340,600 | -4.1% | 0.01% | 0.0% |
| Q4 2019 | $29,945,000 | +13.2% | 355,340 | +0.5% | 0.01% | +14.3% |
| Q3 2019 | $26,452,000 | +10.6% | 353,731 | -6.5% | 0.01% | 0.0% |
| Q2 2019 | $23,923,000 | +43.8% | 378,356 | +9.6% | 0.01% | +40.0% |
| Q1 2019 | $16,635,000 | +50.0% | 345,338 | +4.2% | 0.01% | +66.7% |
| Q4 2018 | $11,093,000 | -45.3% | 331,349 | -14.4% | 0.00% | -40.0% |
| Q3 2018 | $20,292,000 | +77.2% | 387,258 | +5.8% | 0.01% | +66.7% |
| Q2 2018 | $11,453,000 | +163.9% | 365,923 | +83.8% | 0.00% | +200.0% |
| Q1 2018 | $4,340,000 | -14.3% | 199,089 | -20.6% | 0.00% | 0.0% |
| Q4 2017 | $5,065,000 | +25.7% | 250,707 | +23.5% | 0.00% | 0.0% |
| Q3 2017 | $4,030,000 | +16.3% | 203,031 | +1.4% | 0.00% | 0.0% |
| Q2 2017 | $3,465,000 | +146.4% | 200,307 | +15.4% | 0.00% | – |
| Q1 2017 | $1,406,000 | +4.7% | 173,523 | +1.4% | 0.00% | – |
| Q4 2016 | $1,343,000 | +2.6% | 171,043 | +11.6% | 0.00% | – |
| Q3 2016 | $1,309,000 | -18.2% | 153,307 | +11.8% | 0.00% | – |
| Q2 2016 | $1,600,000 | +381.9% | 137,091 | +498.6% | 0.00% | – |
| Q1 2016 | $332,000 | -5.4% | 22,901 | +45.8% | 0.00% | – |
| Q4 2015 | $351,000 | – | 15,705 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $77,833,000 | 15.51% |
| HARTLINE INVESTMENT CORP/ | 302,194 | $67,033,000 | 8.47% |
| Darsana Capital Partners LP | 700,000 | $155,274,000 | 4.42% |
| MORGAN JESS S & CO INC | 23,775 | $5,274,000 | 3.47% |
| Soleus Capital Management, L.P. | 98,975 | $21,955,000 | 3.38% |
| Montanaro Asset Management Ltd | 116,650 | $25,875,000 | 3.26% |
| Taylor Frigon Capital Management LLC | 31,035 | $6,884,000 | 2.15% |
| Rhenman & Partners Asset Management AB | 120,000 | $26,618,000 | 1.81% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $2,218,000 | 1.33% |
| Derbend Asset Management | 5,789 | $1,284,000 | 1.20% |